266 related articles for article (PubMed ID: 29031848)
1. Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis.
Pigott DM; Deshpande A; Letourneau I; Morozoff C; Reiner RC; Kraemer MUG; Brent SE; Bogoch II; Khan K; Biehl MH; Burstein R; Earl L; Fullman N; Messina JP; Mylne AQN; Moyes CL; Shearer FM; Bhatt S; Brady OJ; Gething PW; Weiss DJ; Tatem AJ; Caley L; De Groeve T; Vernaccini L; Golding N; Horby P; Kuhn JH; Laney SJ; Ng E; Piot P; Sankoh O; Murray CJL; Hay SI
Lancet; 2017 Dec; 390(10113):2662-2672. PubMed ID: 29031848
[TBL] [Abstract][Full Text] [Related]
2. Viral haemorrhagic fever.
Fhogartaigh CN; Aarons E
Clin Med (Lond); 2015 Feb; 15(1):61-6. PubMed ID: 25650201
[TBL] [Abstract][Full Text] [Related]
3. [Viral haemorrhagic fevers--evolution of the epidemic potential].
Markin VA; Markov VI
Zh Mikrobiol Epidemiol Immunobiol; 2002; (1):91-8. PubMed ID: 11949268
[TBL] [Abstract][Full Text] [Related]
4. Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.
Colebunders R; Van Esbroeck M; Moreau M; Borchert M
Acta Clin Belg; 2002; 57(5):233-40. PubMed ID: 12534129
[TBL] [Abstract][Full Text] [Related]
5. Emergence of deadly viral haemorrhagic fever disease outbreaks in West Africa.
Vega-Rodriguez W; Ly H
Virulence; 2023 Dec; 14(1):2176980. PubMed ID: 36748841
[TBL] [Abstract][Full Text] [Related]
6. Multi-Pathogen Innovative (5 in 1) Vaccine for Viral Haemorrhagic Fevers will Save More Lives.
Ohanu M; Ezenwugo UC; Nwafia I; Ebede S
West Afr J Med; 2023 Jan; 40(1):121-124. PubMed ID: 36718761
[TBL] [Abstract][Full Text] [Related]
7. Viral haemorrhagic fevers in healthcare settings.
Ftika L; Maltezou HC
J Hosp Infect; 2013 Mar; 83(3):185-92. PubMed ID: 23333147
[TBL] [Abstract][Full Text] [Related]
8. Global Spread of Hemorrhagic Fever Viruses: Predicting Pandemics.
Gonzalez JP; Souris M; Valdivia-Granda W
Methods Mol Biol; 2018; 1604():3-31. PubMed ID: 28986822
[TBL] [Abstract][Full Text] [Related]
9. Lessons from nosocomial viral haemorrhagic fever outbreaks.
Fisher-Hoch SP
Br Med Bull; 2005; 73-74():123-37. PubMed ID: 16373655
[TBL] [Abstract][Full Text] [Related]
10. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
Reuben RC; Danladi MMA; Pennap GR
J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
[TBL] [Abstract][Full Text] [Related]
11. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.
Zumla A; Dar O; Kock R; Muturi M; Ntoumi F; Kaleebu P; Eusebio M; Mfinanga S; Bates M; Mwaba P; Ansumana R; Khan M; Alagaili AN; Cotten M; Azhar EI; Maeurer M; Ippolito G; Petersen E
Int J Infect Dis; 2016 Jun; 47():5-9. PubMed ID: 27321961
[TBL] [Abstract][Full Text] [Related]
12. Trends of major disease outbreaks in the African region, 2003-2007.
Kebede S; Duales S; Yokouide A; Alemu W
East Afr J Public Health; 2010 Mar; 7(1):20-9. PubMed ID: 21413568
[TBL] [Abstract][Full Text] [Related]
13. The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic.
Schafer IJ; Knudsen E; McNamara LA; Agnihotri S; Rollin PE; Islam A
J Infect Dis; 2016 Oct; 214(suppl 3):S122-S136. PubMed ID: 27587635
[TBL] [Abstract][Full Text] [Related]
14. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
Shearer FM; Longbottom J; Browne AJ; Pigott DM; Brady OJ; Kraemer MUG; Marinho F; Yactayo S; de Araújo VEM; da Nóbrega AA; Fullman N; Ray SE; Mosser JF; Stanaway JD; Lim SS; Reiner RC; Moyes CL; Hay SI; Golding N
Lancet Glob Health; 2018 Mar; 6(3):e270-e278. PubMed ID: 29398634
[TBL] [Abstract][Full Text] [Related]
15. Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response.
Hulland EN; Wiens KE; Shirude S; Morgan JD; Bertozzi-Villa A; Farag TH; Fullman N; Kraemer MUG; Miller-Petrie MK; Gupta V; Reiner RC; Rabinowitz P; Wasserheit JN; Bell BP; Hay SI; Weiss DJ; Pigott DM
BMC Med; 2019 Dec; 17(1):232. PubMed ID: 31888667
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects of viral hemorrhagic fever].
Saijo M
Nihon Rinsho; 2005 Dec; 63(12):2161-6. PubMed ID: 16363689
[TBL] [Abstract][Full Text] [Related]
17. Nososcomial transmission of viral haemorrhagic fever in South Africa.
Richards GA
S Afr Med J; 2015 Sep; 105(9):709-12. PubMed ID: 26428962
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks.
Simulundu E; Mweene AS; Changula K; Monze M; Chizema E; Mwaba P; Takada A; Ippolito G; Kasolo F; Zumla A; Bates M
Rev Med Virol; 2016 Nov; 26(6):446-454. PubMed ID: 27593704
[TBL] [Abstract][Full Text] [Related]
20. Viral haemorrhagic fever in children.
MacDermott NE; De S; Herberg JA
Arch Dis Child; 2016 May; 101(5):461-8. PubMed ID: 26787609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
